Data as of November 12, 2026
Deblitane 0.35 mg Tablet
NORETHINDRONE
Brand: DEBLITANE
Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.
Price per fill
NADAC (acquisition)
$5.42/ fill$0.10 / EA
FUL
$4.93/ fill$0.09 / EA
AMP
$2.60/ fill$0.05 / EA
Medicaid FFS
$16.66/ fill
Medicaid MCO
$10.79/ fill
Sources: cms/nadac:price-ladder · cms/ful:generic-ceiling · cms/sdud
What's in the reimbursement
Ingredient cost (55.2 units/fill)$5.42
Dispensing fee & other (state-fixed, not margin)$11.24
Total reimbursed per fill$16.66
The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.
Medicaid volume backing this card: 11 fee-for-service states, 20 managed-care states.
Full methodology and source columns: /tools/drug-prices/methodology